Nov 4 (Reuters) - Pfizer ( PFE ) lifted its full-year

profit forecast for the second time in a row on Tuesday, buoyed

by strong demand for its blockbuster heart treatment and blood

thinner.

The company said it expects adjusted earnings of $3.00 to

$3.15 per share, up from its prior view of $2.90 to $3.10.

(Reporting by Mrinalika Roy and Christy Santhosh in Bengaluru;

Editing by Saumyadeb Chakrabarty)